Taq1A and Other Genetic Variants of the Reward System Associated With Substance Use
Main Article Content
Abstract
Introduction: the Taq1A polymorphism (rs1800497) of the ANKK1 gene, which encodes the ankyrin repeat enzyme and the kinase domain containing 1, has been extensively studied in substance abuse and behavioral disorders. Taq1A is associated with alterations to the dopaminergic system in the brain reward system through the dopamine receptor 2.
Method: a documentary review was performed in the electronic database PubMed between the years 2008 to 2023.
Results: we consulted 85 articles that met the inclusion criteria. The present review shows the evidence of genes involved in the brain reward pathway that sums up the importance of the various genetic variants besides Taq1A, which are associated with substance use.
Discussion and conclusions: risk genes associated with the consumption of specific substances of abuse are linked to the reward system through diverse neurotransmitters, resulting in a network of genetic variants that may interact between them to promote the development of addiction.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Śmiarowska, M., Brzuchalski, B., Grzywacz, E., Malinowski, D., Machoy-Mokrzyńska, A., Pierzchlińska, A., & Białecka, M. (2022). Influence of COMT (rs4680) and DRD2 (rs1076560, rs1800497) Gene Polymorphisms on Safety and Efficacy of Methylphenidate Treatment in Children with Fetal Alcohol Spectrum Disorders. International Journal of Environmental Research and Public Health, 19(8), 4479. https://doi.org/10.3390/ijerph19084479
Abdulmalek, S., & Hardiman, G. (2023). Genetic and epigenetic studies of opioid abuse disorder – the potential for future diagnostics. Expert Review of Molecular Diagnostics, 23(5), 361-373. https://doi.org/10.1080/14737159.2023.2190022
Agrawal, A., Verweij, K. J. H., Gillespie, N. A., Heath, A. C., Lessov-Schlaggar, C. N., Martin, N. G., Nelson, E. C., Slutske, W. S., Whitfield, J. B., & Lynskey, M. T. (2012). The genetics of addiction—a translational perspective. Translational Psychiatry, 2(7), e140. https://doi.org/10.1038/tp.2012.54
Bidwell, L. C., McGeary, J. E., Gray, J. C., Palmer, R. H. C., Knopik, V. S., & MacKillop, J. (2015a). An initial investigation of associations between dopamine-linked genetic variation and smoking motives in African Americans. Pharmacology Biochemistry and Behavior, 138, 104-110. https://doi.org/10.1016/j.pbb.2015.09.018
Bidwell, L. C., McGeary, J. E., Gray, J. C., Palmer, R. H. C., Knopik, V. S., & MacKillop, J. (2015b). NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence. Psychopharmacology, 232(7), 1177-1186. https://doi.org/10.1007/s00213-014-3748-2
Breitling, L. P., Twardella, D., Hoffmann, M. M., Witt, S. H., Treutlein, J., & Brenner, H. (2010). Prospective association of dopamine-related polymorphisms with smoking cessation in general care. Pharmacogenomics, 11(4), 527-536. https://doi.org/10.2217/pgs.10.1
Cai, M., Su, Z., Zou, H., Zhang, Q., Shen, J., Zhang, L., Wang, T., Yang, Z., & Li, C. (2015). Association between the traditional Chinese medicine pathological factors of opioid addiction and DRD2/ANKK1 TaqI1A polymorphisms. BMC Complementary and Alternative Medicine, 15(1). https://doi.org/10.1186/s12906-015-0727-z
Celorrio, D., Muñoz, X., Amiano, P., Dorronsoro, M., Bujanda, L., Sánchez, M.-J., Molina-Montes, E., Navarro, C., Chirlaque, M. D., Huerta, J. M., Ardanaz, E., Barricarte, A., Rodriguez, L., Duell, E. J., Hijona, E., Herreros-Villanueva, M., Sala, N., Alfonso-Sánchez, M. A., & de Pancorbo, M. M. (2016). Influence of Dopaminergic System Genetic Variation and Lifestyle Factors on Excessive Alcohol Consumption. Alcohol and Alcoholism, 51(3), 258-267. https://doi.org/10.1093/alcalc/agv114
Chmielowiec, K., Chmielowiec, J., Masiak, J., Stroǹska-Pluta, A., Śmiarowska, M., Boroń, A., & Grzywacz, A. (2022). Associations between the COMT rs4680 Gene Polymorphism and Personality Dimensions and Anxiety in Patients with a Diagnosis of Other Stimulants Dependence. Genes, 13(10), 1768. https://doi.org/10.3390/genes13101768
Clark, S. L., McClay, J. L., Adkins, D. E., Kumar, G., Aberg, K. A., Nerella, S., Xie, L., Collins, A. L., Crowley, J. J., Quackenbush, C. R., Hilliard, C. E., Shabalin, A. A., Vrieze, S. I., Peterson, R. E., Copeland, W. E., Silberg, J. L., McGue, M., Maes, H., Iacono, W. G., ... van den Oord, E. J. (2017). Deep Sequencing of 71 Candidate Genes to Characterize Variation Associated with Alcohol Dependence. Alcoholism: Clinical and Experimental Research, 41(4), 711-718. https://doi.org/10.1111/acer.13352
Codina, L. (2022). El modelo IMRyD de artículos científicos: ¿qué es y cómo se puede aplicar en humanidades y ciencias sociales? Hipertext.net, 24, 1-8. https://doi.org/10.31009/hipertext.net.2022.i24.01
Deng, X.-D., Jiang, H., Ma, Y., Gao, Q., Zhang, B., Mu, B., Zhang, L.-X., Zhang, W., Er, Z.-E. M., Xie, Y., & Liu, Y. (2015). Association between DRD2/ANKK1 TaqIA polymorphism and common illicit drug dependence: Evidence from a meta-analysis. Human Immunology, 76(1), 42-51. https://doi.org/10.1016/j.humimm.2014.12.005
Doran, N., Schweizer, C. A., Myers, M. G., & Greenwood, T. A. (2013). A Prospective Study of the Effects of the DRD2/ANKK1 TaqIA Polymorphism and Impulsivity on Smoking Initiation. Substance Use & Misuse, 48(1-2), 106-116. https://doi.org/10.3109/10826084.2012.733791
Esposito-Smythers, C., Spirito, A., Rizzo, C., McGeary, J. E., & Knopik, V. S. (2009). Associations of the DRD2 Taq1A polymorphism with impulsivity and substance use: Preliminary results from a clinical sample of adolescents. Pharmacology Biochemistry and Behavior, 93(3), 306-312. https://doi.org/10.1016/j.pbb.2009.03.012
Fernàndez-Castillo, N., Ribasés, M., Roncero, C., Casas, M., Gonzalvo, B., & Cormand, B. (2010). Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample. Psychiatric Genetics, 20(6), 317-320. https://doi.org/10.1097/YPG.0b013e32833b6320
Fiatal, S., Tóth, R., Moravcsik-Kornyicki, Á., Kósa, Z., Sándor, J., McKee, M., & Ádány, R. (2016). High Prevalence of Smoking in the Roma Population Seems to Have No Genetic Background. Nicotine & Tobacco Research, 18(12), 2260-2267. https://doi.org/10.1093/ntr/ntw161
Forrester, S. Y., & Jahan, N. (2020). Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus, 12(4). https://doi.org/10.7759/cureus.7759
García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Navarro, D., Morcuende, Á., Femenía, T., & Manzanares, J. (2022). Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies. International Journal of Molecular Sciences, 23(11), 5908. https://doi.org/10.3390/ijms23115908
Gerra, M. C., Jayanthi, S., Manfredini, M., Walther, D., Schroeder, J., Phillips, K. A., Cadet, J. L., & Donnini, C. (2018). Gene variants and educational attainment in cannabis use: mediating role of DNA methylation. Translational Psychiatry, 8(1). https://doi.org/10.1038/s41398-017-0087-1
Gerra, M. C., Manfredini, M., Cortese, E., Antonioni, M. C., Leonardi, C., Magnelli, F., Somaini, L., Jayanthi, S., Cadet, J. L., & Donnini, C. (2019). Genetic and Environmental Risk Factors for Cannabis Use: Preliminary Results for the Role of Parental Care Perception. Substance Use & Misuse, 54(4), 670-680. https://doi.org/10.1080/10826084.2018.1531430
Gordiev, M., Engstrom, P. F., Khasanov, R., Moroshek, A., Sitdikov, R., Dgavoronkov, V., & Schnoll, R. A. (2013). Genetic Analysis of Polymorphisms in Dopamine Receptor and Transporter Genes for Association with Smoking among Cancer Patients. European Addiction Research, 19(2), 105-111. https://doi.org/10.1159/000341711
Grimm, O., van Rooij, D., Hoogman, M., Klein, M., Buitelaar, J., Franke, B., Reif, A., & Plichta, M. M. (2021). Transdiagnostic neuroimaging of reward system phenotypes in ADHD and comorbid disorders. Neuroscience & Biobehavioral Reviews, 128, 165-181. https://doi.org/10.1016/j.neubiorev.2021.06.025
Grzywacz, A., Chmielowiec, J., Chmielowiec, K., Mroczek, B., Masiak, J., Suchanecka, A., Sipak-Szmigiel, O., Szumilas, K., & Trybek, G. (2019). The Ankyrin Repeat and Kinase Domain Containing 1 Gene Polymorphism (ANKK1 Taq1A) and Personality Traits in Addicted Subjects. International Journal of Environmental Research and Public Health, 16(15), 2687. https://doi.org/10.3390/ijerph16152687
Grzywacz, A., Jasiewicz, A., Małecka, I., Suchanecka, A., Grochans, E., Karakiewicz, B., Samochowiec, A., Bieńkowski, P., & Samochowiec, J. (2012). Influence of DRD2 and ANKK1 polymorphisms on the manifestation of withdrawal syndrome symptoms in alcohol addiction. Pharmacological Reports, 64(5), 1126-1134. https://doi.org/10.1016/S1734-1140(12)70909-X
Gullo, M. J., St. John, N., Young, R. M., Saunders, J. B., Noble, E. P., & Connor, J. P. (2014). Impulsivity-related cognition in alcohol dependence: Is it moderated by DRD2/ANKK1 gene status and executive dysfunction? Addictive Behaviors, 39(11), 1663-1669. https://doi.org/10.1016/j.addbeh.2014.02.004
Harp, S. J., Martini, M., Lynch, W. J., & Rissman, E. F. (2020). Sexual Differentiation and Substance Use: A Mini-Review. Endocrinology, 161(9). https://doi.org/10.1210/endocr/bqaa129
Heinrich, A., Müller, K. U., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Bromberg, U., Büchel, C., Conrod, P., Fauth-Bühler, M., Papadopoulos, D., Gallinat, J., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Mann, K., Martinot, J.-L., Paus, T., Pausova, Z., ... Nees, F. (2016). Prediction of alcohol drinking in adolescents: Personality-traits, behavior, brain responses, and genetic variations in the context of reward sensitivity. Biological Psychology, 118, 79-87. https://doi.org/10.1016/j.biopsycho.2016.05.002
Herman, A. I., DeVito, E. E., Jensen, K. P., & Sofuoglu, M. (2014). Pharmacogenetics of nicotine addiction: role of dopamine. Pharmacogenomics, 15(2), 221-234. https://doi.org/10.2217/pgs.13.246
Hirasawa-Fujita, M., Bly, M. J., Ellingrod, V. L., Dalack, G. W., & Domino, E. F. (2017). Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder. Clinical Schizophrenia & Related Psychoses, 11(1), 39-48. https://doi.org/10.3371/1935-1232-11.1.39
Hou, Q.-F., & Li, S.-B. (2009). Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neuroscience Letters, 464(2), 127-130. https://doi.org/10.1016/j.neulet.2009.08.004
Huang, C.-L., Ou, W.-C., Chen, P.-L., Liu, C.-N., Chen, M.-C., Lu, C.-C., Chen, Y.-C., Lin, M.-H., & Huang, C.-S. (2015). Effects of Interaction Between Dopamine D2 Receptor and Monoamine Oxidase A Genes on Smoking Status in Young Men. Biological Research for Nursing, 17(4), 422-428. https://doi.org/10.1177/1099800415589366
Huang, W., Payne, T. J., Ma, J. Z., Beuten, J., Dupont, R. T., Inohara, N., & Li, M. D. (2009). Significant Association of ANKK1 and Detection of a Functional Polymorphism with Nicotine Dependence in an African-American Sample. Neuropsychopharmacology, 34(2), 319-330. https://doi.org/10.1038/npp.2008.37
Jasiewicz, A., Samochowiec, A., Samochowiec, J., Małecka, I., Suchanecka, A., & Grzywacz, A. (2014). Suicidal Behavior and Haplotypes of the Dopamine Receptor Gene (DRD2) and ANKK1 Gene Polymorphisms in Patients with Alcohol Dependence – Preliminary Report. PLoS One, 9(11), e111798. https://doi.org/10.1371/journal.pone.0111798
Johnson, E. C., Demontis, D., Thorgeirsson, T., Walters, R., Polimanti, R., Hatoum, A., Sanchez-Roige, S., Paul, S., Wendt, F., Clarke, T., Lai, D., Reginsson, G., Zhou, H., He, J., Baranger, D., Gudbjartsson, D., Wedow, R., Adkins, D., Adkins, A., …Agrawal, A. (2020). A large-scale genome-wide association study meta-analysis of cannabis use disorder. The Lancet Psychiatry, 7(12), 1032-1045. https://doi.org/10.1016/S2215-0366(20)30339-4
Jung, Y., Montel, R. A., Shen, P.-H., Mash, D. C., & Goldman, D. (2019). Assessment of the Association of D2 Dopamine Receptor Gene and Reported Allele Frequencies With Alcohol Use Disorders: A Systematic Review and Meta-analysis. JAMA Network Open, 2(11), e1914940. https://doi.org/10.1001/jamanetworkopen.2019.14940
Kaminskaite, M., Jokubka, R., Janaviciute, J., Lelyte, I., Sinkariova, L., Pranckeviciene, A., Borutaite, V., & Bunevicius, A. (2021). Epistatic effect of Ankyrin repeat and kinase domain containing 1 – Dopamine receptor D2 and catechol-o-methyltransferase single nucleotide polymorphisms on the risk for hazardous use of alcohol in Lithuanian population. Gene, 765, 145107. https://doi.org/10.1016/j.gene.2020.145107
Kasiakogia-Worlley, K., McQuillin, A., Lydall, G. J., Patel, S., Kottalgi, G., Gunwardena, P., Cherian, R., Rao, H., Hillman, A., Gobikrishnan, N., Douglas, E., Qureshi, S. Y., Jauhar, S., Ball, D., O’Kane, A., Owens, L., Dedman, A., Sharp, S. I., Kandaswamy, R., ... Gurling, H. M. D. (2011). Lack of allelic association between markers at the DRD2 and ANKK1 gene loci with the alcohol-dependence syndrome and criminal activity. Psychiatric Genetics, 21(6), 323-324. https://doi.org/10.1097/YPG.0b013e3283458a68
Koeneke, A., Ponce, G., Troya-Balseca, J., Palomo, T., & Hoenicka, J. (2020). Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability. International Journal of Molecular Sciences, 21(7), 2516. https://doi.org/10.3390/ijms21072516
Kovanen, L., Saarikoski, S. T., Haukka, J., Pirkola, S., Aromaa, A., Lönnqvist, J., & Partonen, T. (2010). Circadian Clock Gene Polymorphisms in Alcohol Use Disorders and Alcohol Consumption. Alcohol and Alcoholism, 45(4), 303-311. https://doi.org/10.1093/alcalc/agq035
Lachowicz, M., Chmielowiec, J., Chmielowiec, K., Suchanecka, A., Masiak, J., Michałowska-Sawczyn, M., Mroczek, B., Mierzecki, A., Ciechanowicz, I., & Grzywacz, A. (2020). Significant association of DRD2 and ANKK1 genes with rural heroin dependence and relapse in men. Annals of Agricultural and Environmental Medicine, 27(2), 269-273. https://doi.org/10.26444/aaem/119940
Lee, S. H., Lee, B.-H., Lee, J.-S., Chai, Y. G., Choi, M. R., Han, D. M. R., Ji, H., Jang, G.-H., Shin, H. E., & Choi, I. G. (2013). The Association of DRD2 −141C and ANKK1 TaqIA Polymorphisms with Alcohol Dependence in Korean Population Classified by the Lesch Typology. Alcohol and Alcoholism, 48(4), 426-432. https://doi.org/10.1093/alcalc/agt029
Levran, O., Peles, E., Randesi, M., Shu, X., Ott, J., Shen, P.-H., Adelson, M., & Kreek, M. J. (2013). Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics, 14(7), 755-768. https://doi.org/10.2217/pgs.13.58
Liu, Q., Xu, Y., Mao, Y., Ma, Y., Wang, M., Han, H., Cui, W., Yuan, W., Payne, T. J., Xu, Y., Li, M. D., & Yang, Z. (2020). Genetic and Epigenetic Analysis Revealing Variants in the NCAM1–TTC12–ANKK1–DRD2 Cluster Associated Significantly With Nicotine Dependence in Chinese Han Smokers. Nicotine & Tobacco Research, 22(8), 1301-1309. https://doi.org/10.1093/ntr/ntz240
Lobo, D. S. S., Zawertailo, L., Selby, P., & Kennedy, J. L. (2012). The role of ANKK1 and TTC12 genes on drinking behaviour in tobacco dependent subjects. The World Journal of Biological Psychiatry, 13(3), 232-238. https://doi.org/10.3109/15622975.2011.598560
Lu, R.-B., Lee, J.-F., Huang, S.-Y., Lee, S.-Y., Chang, Y.-H., Kuo, P.-H., Chen, S.-L., Chen, S.-H., Chu, C.-H., Lin, W.-W., Wu, P.-L., & Ko, H.-C. (2012). Interaction between ALDH2*1*1 and DRD2/ANKK1 TaqI A1A1 genes may be associated with antisocial personality disorder not co-morbid with alcoholism. Addiction Biology, 17(5), 865-874. https://doi.org/10.1111/j.1369-1600.2010.00268.x
Ma, Y., Wang, M., Yuan, W., Su, K., & Li, M. D. (2015a). The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations. Translational Psychiatry, 5(12), e686. https://doi.org/10.1038/tp.2015.176
Ma, Y., Yuan, W., Jiang, X., Cui, W. Y., & Li, M. D. (2015b). Updated Findings of the Association and Functional Studies of DRD2/ANKK1 Variants with Addictions. Molecular Neurobiology, 51(1), 281-299. https://doi.org/10.1007/s12035-014-8826-2
Macare, C., Ducci, F., Zhang, Y., Ruggeri, B., Jia, T., Kaakinen, M., Kalsi, G., Charoen, P., Casoni, F., Peters, J., Bromberg, U., Hill, M., Buxton, J., Blakemore, A., Veijola, J., Büchel, C., Banaschewski, T., Bokde, A. L. W., Conrod, P., ... Schumann, G. (2018). A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response. European Neuropsychopharmacology, 28(10), 1103-1114. https://doi.org/10.1016/j.euroneuro.2018.07.101
Mayer, O., Seidlerová, J., Ĉerná, V., Kučerová, A., Bruthans, J., Vágovičová, P., Vaněk, J., Timoracká, K., Wohlfahrt, P., Filipovský, J., Cífková, R., & Pešta, M. (2015). The DRD2/ANKK1 Taq1A polymorphism is associated with smoking cessation failure in patients with coronary heart disease. Personalized Medicine, 12(5), 463-473. https://doi.org/10.2217/pme.15.16
Mignini, F., Napolioni, V., Codazzo, C., Carpi, F. M., Vitali, M., Romeo, M., & Ceccanti, M. (2012). DRD2/ANKK1 TaqIA and SLC6A3 VNTR polymorphisms in alcohol dependence: Association and gene–gene interaction study in a population of Central Italy. Neuroscience Letters, 522(2), 103-107. https://doi.org/10.1016/j.neulet.2012.06.008
Munafò, M. R., Johnstone, E. C., Murphy, M. F. G., & Aveyard, P. (2009). Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial. Nicotine & Tobacco Research, 11(4), 404-407. https://doi.org/10.1093/ntr/ntp007
Neville, M. J., Johnstone, E. C., & Walton, R. T. (2004). Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Human Mutation, 23(6), 540-545. https://doi.org/10.1002/humu.20039
Ohmoto, M., Takahashi, T., Kubota, Y., Kobayashi, S., & Mitsumoto, Y. (2014). Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population. BMC Genetics, 15, 151. https://doi.org/10.1186/s12863-014-0151-2
Panduro, A., Ramos-Lopez, O., Campollo, O., Zepeda-Carrillo, E. A., Gonzalez-Aldaco, K., Torres-Valadez, R., & Roman, S. (2017). High frequency of the DRD2/ANKK1 A1 allele in Mexican Native Amerindians and Mestizos and its association with alcohol consumption. Drug and Alcohol Dependence, 172, 66-72. https://doi.org/10.1016/j.drugalcdep.2016.12.006
Park, C. I., Kim, H. W., Hwang, S. S., Kang, J. I., & Kim, S. J. (2021). Influence of dopamine-related genes on craving, impulsivity, and aggressiveness in Korean males with alcohol use disorder. European Archives of Psychiatry and Clinical Neuroscience, 271(5), 865-872. https://doi.org/10.1007/s00406-019-01072-3
Radwan, G. N., El-Setouhy, M., Mohamed, M. K., Hamid, M. A., Azem, S. A., Kamel, O., Israel, E., & Loffredo, C. A. (2007). DRD2/ANKK1 Taq1APolymorphism and Smoking Behavior of Egyptian Male Cigarette Smokers. Nicotine & Tobacco Research, 9(12), 1325-1329. https://doi.org/10.1080/14622200701704889
Ramoz, N., & Gorwood, P. (2015). Les addictions sous l’angle de la génétique. Médecine/Sciences, 31(4), 432-438. https://doi.org/10.1051/medsci/20153104018
Ramoz, N., & Gorwood, P. (2018). Aspects génétiques de l’alcoolo-dépendance. La Presse Médicale, 47(6), 547-553. https://doi.org/10.1016/j.lpm.2017.07.007
Ribeiro, E. A., Scarpa, J. R., Garamszegi, S. P., Kasarskis, A., Mash, D. C., & Nestler, E. J. (2017). Gene Network Dysregulation in Dorsolateral Prefrontal Cortex Neurons of Humans with Cocaine Use Disorder. Scientific Reports, 7(1), 5412. https://doi.org/10.1038/s41598-017-05720-3
Ruzilawati, A. B., Islam, A., Muhamed, S. K. S., & Ahmad, I. (2020). Smoking Genes: A Case–Control Study of Dopamine Transporter Gene (SLC6A3) and Dopamine Receptor Genes (DRD1, DRD2 and DRD3) Polymorphisms and Smoking Behaviour in a Malay Male Cohort. Biomolecules, 10(12), 1633. https://doi.org/10.3390/biom10121633
Samochowiec, A., Chęć, M., Kopaczewska, E., Samochowiec, J., Lesch, O., Jasiewicz, A., Grochans, E., Jabłoński, M., Bieńkowski, P., Kołodziej, Ł., & Grzywacz, A. (2016). Case control study of ANKK1 Taq 1A polymorphism in patients with alcohol dependence classified according to Lesch’s typology. Postępy Higieny I Medycyny Doświadczalnej,
, 420-424. https://doi.org/10.5604/17322693.1201125
Schellekens, A. F. A., Franke, B., Ellenbroek, B., Cools, A., de Jong, C. A. J., Buitelaar, J. K., & Verkes, R.-J. (2013). COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence. Addiction Biology, 18(2), 344-356. https://doi.org/10.1111/j.1369-1600.2012.00438.x
Singh, H. S., Ghosh, P. K., & Saraswathy, K. N. (2013). DRD2 and ANKK1 Gene Polymorphisms and Alcohol Dependence: A Case–Control Study among a Mendelian Population of East Asian Ancestry. Alcohol and Alcoholism, 48(4), 409-414. https://doi.org/10.1093/alcalc/agt014
Smith, N. D. L., & Cottler, L. B. (2020). What’s old is new again: updated findings on personality disorders and substance use disorders. Current Opinion in Psychiatry, 33(1), 51-56. https://doi.org/10.1097/YCO.0000000000000558
Spellicy, C. J., Harding, M. J., Hamon, S. C., Mahoney, J. J., Reyes, J. A., Kosten, T. R., Newton, T. F., De La Garza, R., & Nielsen, D. A. (2014). A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study. Genes, Brain and Behavior, 13(6), 559-564. https://doi.org/10.1111/gbb.12121
Spellicy, C. J., Kosten, T. R., Hamon, S. C., Harding, M. J., & Nielsen, D. A. (2013). ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse. Pharmacogenetics and Genomics, 23(7), 333-340. https://doi.org/10.1097/FPC.0b013e328361c39d
Spitta, G., Fliedner, L. E., Gleich, T., Zindler, T., Sebold, M., Buchert, R., Heinz, A., Gallinat, J., & Friedel, E. (2022). Association between DRD2/ANKK1 Taq1A Allele Status and Striatal Dopamine D2/3 Receptor Availability in Alcohol Use Disorder. Journal of Integrative Neuroscience, 21(6), 171. https://doi.org/10.31083/j.jin2106171
Spronk, D. B., Van der Schaaf, M. E., Cools, R., De Bruijn, E. R. A., Franke, B., van Wel, J. H. P., Ramaekers, J. G., & Verkes, R. J. (2016). Acute effects of cocaine and cannabis on reversal learning as a function of COMT and DRD2 genotype. Psychopharmacology, 233(2), 199-211. https://doi.org/10.1007/s00213-015-4141-5
Stapleton, J. A., Sutherland, G., O’Gara, C., Spirling, L. I., & Ball, D. (2011). Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy. Pharmacogenetics and Genomics, 21(8), 447-453. https://doi.org/10.1097/FPC.0b013e328347473a
Svyryd, Y., Ramírez-Venegas, A., Sánchez-Hernández, B., Aguayo-Gómez, A., Luna-Muñoz, L., Arteaga-Vázquez, J., Regalado-Pineda, J., & Mutchinick, O. M. (2016). Genetic Risk Determinants for Cigarette Smoking Dependence in Mexican Mestizo Families. Nicotine & Tobacco Research, 18(5), 620-625. https://doi.org/10.1093/ntr/ntv213
Swagell, C. D., Lawford, B. R., Hughes, I. P., Voisey, J., Feeney, G. F. X., van Daal, A., Connor, J. P., Noble, E. P., Morris, C. P., & Young, R. McD. (2012). DRD2 C957T and TaqIA Genotyping Reveals Gender Effects and Unique Low-Risk and High-Risk Genotypes in Alcohol Dependence. Alcohol and Alcoholism, 47(4), 397-403. https://doi.org/10.1093/alcalc/ags047
Tomaz, P. R. X., Santos, J. R., Issa, J. S., Abe, T. O., Gaya, P. V., Krieger, J. E., Pereira, A. C., & Santos, P. C. J. L. (2015). CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy. European Journal of Clinical Pharmacology, 71(9), 1067-1073. https://doi.org/10.1007/s00228-015-1896-x
Tsou, C.-C., Chou, H.-W., Ho, P.-S., Kuo, S.-C., Chen, C.-Y., Huang, C.-C., Liang, C.-S., Lu, R.-B., & Huang, S.-Y. (2019). DRD2 and ANKK1 genes associate with late-onset heroin dependence in men. The World Journal of Biological Psychiatry, 20(8), 605-615. https://doi.org/10.1080/15622975.2017.1372630
Vasconcelos, A. C. C. G., Neto, E. de S. R., Pinto, G. R., Yoshioka, F. K. N., Motta, F. J. N., Vasconcelos, D. F. P., & Canalle, R. (2015). Association Study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A Polymorphisms with Alcohol Dependence in a Population from Northeastern Brazil. Alcoholism: Clinical and Experimental Research, 39(2), 205-211. https://doi.org/10.1111/acer.12625
Vaske, J. (2013). Interaction of the TaqIA Polymorphism and Poor Parental Socialization on Changes in Adolescent Marijuana Use. Substance Use & Misuse, 48(3), 258-264. https://doi.org/10.3109/10826084.2012.754898
Verde, Z., Santiago, C., Rodríguez González-Moro, J. M., de Lucas Ramos, P., López Martín, S., Bandrés, F., Lucia, A., & Gómez-Gallego, F. (2011). ‘Smoking Genes’: A Genetic Association Study. PLoS One, 6(10), e26668. https://doi.org/10.1371/journal.pone.0026668
Verdejo-Garcia, A., Clark, L., Verdejo-Román, J., Albein-Urios, N., Martinez-Gonzalez, J. M., Gutierrez, B., & Soriano-Mas, C. (2015). Neural substrates of cognitive flexibility in cocaine and gambling addictions. British Journal of Psychiatry, 207(2), 158-164. https://doi.org/10.1192/bjp.bp.114.152223
Vereczkei, A., Demetrovics, Z., Szekely, A., Sarkozy, P., Antal, P., Szilagyi, A., Sasvari-Szekely, M., & Barta, C. (2013). Multivariate Analysis of Dopaminergic Gene Variants as Risk Factors of Heroin Dependence. PLoS One, 8(6), e66592. https://doi.org/10.1371/journal.pone.0066592
Villalba, K., Devieux, J. G., Rosenberg, R., & Cadet, J. L. (2015). DRD2 and DRD4 genes related to cognitive deficits in HIV-infected adults who abuse alcohol. Behavioral and Brain Functions, 11, 25. https://doi.org/10.1186/s12993-015-0072-x
Vink, J. M., Hottenga, J. J., de Geus, E. J., Willemsen, G., Neale, M. C., Furberg, H., & Boomsma, D. I. (2014). Polygenic risk scores for smoking: predictors for alcohol and cannabis use?. Addiction, 109(7), 1141-1151. https://doi.org/10.1111/add.12491
Vizeli, P., & Liechti, M. E. (2019). No Influence of Dopamine System Gene Variations on Acute Effects of MDMA. Frontiers in Psychiatry, 10, 755. https://doi.org/10.3389/fpsyt.2019.00755
Voisey, J., Swagell, C. D., Hughes, I. P., van Daal, A., Noble, E. P., Lawford, B. R., Young, R. M., & Morris, C. P. (2012). A DRD2 and ANKK1 haplotype is associated with nicotine dependence. Psychiatry Research, 196(2-3), 285-289. https://doi.org/10.1016/j.psychres.2011.09.024
Wang, F., Simen, A., Arias, A., Lu, Q.-W., & Zhang, H. (2013). A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Human Genetics, 132(3), 347-358. https://doi.org/10.1007/s00439-012-1251-6
Weafer, J., Gray, J. C., Hernandez, K., Palmer, A. A., MacKillop, J., & de Wit, H. (2017). Hierarchical investigation of genetic influences on response inhibition in healthy young adults. Experimental and Clinical Psychopharmacology, 25(6), 512-520. https://doi.org/10.1037/pha0000156
Wilcox, C. S., Noble, E. P., & Oskooilar, N. (2011). ANKK1/DRD2 Locus Variants Are Associated With Rimonabant Efficacy in Aiding Smoking Cessation. Journal of Investigative Medicine, 59(8), 1280-1283. https://doi.org/10.2310/JIM.0b013e31823581fa
Yang, Z., Zhao, W., Linli, Z., Guo, S., & Feng, J. (2023). Associations between polygenic risk scores and accelerated brain ageing in smokers. Psychological Medicine, 53(16), 7785-7794. https://doi.org/10.1017/S0033291723001812
Zhang, J., Yan, P., Li, Y., Cai, X., Yang, Z., Miao, X., Chen, B., Li, S., Dang, W., Jia, W., & Zhu, Y. (2018). A 35.8 kilobases haplotype spanning ANKK1 and DRD2 is associated with heroin dependence in Han Chinese males. Brain Research, 1688, 54-64. https://doi.org/10.1016/j.brainres.2018.03.017